Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population

Vaccination is a key control measure of coronavirus disease 2019 by preventing severe effects of disease outcomes, reducing hospitalization rates and death, and increasing immunity. However, vaccination can affect the evolution and adaptation of SARS-CoV-2 largely through vaccine-induced immune pres...

Full description

Bibliographic Details
Main Authors: Lugano, Doreen, Mwangi, Kennedy, Mware, Bernard, Kibet, Gilbert, Osiany, Shebbar, Kiritu, Edward, Dobi, Paul, Muli, Collins, Njeru, Regina, Oliveira, T. de, Njenga, M.K., Routh, A., Oyola, Samuel O.
Other Authors: Schultz-Cherry, Stacey
Format: Journal Article
Language:Inglés
Published: American Society for Microbiology 2025
Subjects:
Online Access:https://hdl.handle.net/10568/174472
_version_ 1855535269543936000
author Lugano, Doreen
Mwangi, Kennedy
Mware, Bernard
Kibet, Gilbert
Osiany, Shebbar
Kiritu, Edward
Dobi, Paul
Muli, Collins
Njeru, Regina
Oliveira, T. de
Njenga, M.K.
Routh, A.
Oyola, Samuel O.
author2 Schultz-Cherry, Stacey
author_browse Dobi, Paul
Kibet, Gilbert
Kiritu, Edward
Lugano, Doreen
Muli, Collins
Mwangi, Kennedy
Mware, Bernard
Njenga, M.K.
Njeru, Regina
Oliveira, T. de
Osiany, Shebbar
Oyola, Samuel O.
Routh, A.
Schultz-Cherry, Stacey
author_facet Schultz-Cherry, Stacey
Lugano, Doreen
Mwangi, Kennedy
Mware, Bernard
Kibet, Gilbert
Osiany, Shebbar
Kiritu, Edward
Dobi, Paul
Muli, Collins
Njeru, Regina
Oliveira, T. de
Njenga, M.K.
Routh, A.
Oyola, Samuel O.
author_sort Lugano, Doreen
collection Repository of Agricultural Research Outputs (CGSpace)
description Vaccination is a key control measure of coronavirus disease 2019 by preventing severe effects of disease outcomes, reducing hospitalization rates and death, and increasing immunity. However, vaccination can affect the evolution and adaptation of SARS-CoV-2 largely through vaccine-induced immune pressure. Here, we investigated intrahost recombination and single nucleotide variations (iSNVs) on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome in non-vaccinated and vaccinated sequences from the Kenyan population to profile intrahost viral genetic evolution and adaptations driven by vaccine-induced immune pressure. We identified recombination hotspots in the S, N, and ORF1a/b genes and showed the genetic evolution landscape of SARS-CoV-2 by comparing within- and inter-wave recombination events from the beginning of the pandemic (June 2020 to December 2022) in Kenya. We further reveal differential expression of recombinant RNA species between vaccinated and non-vaccinated individuals and perform an in-depth analysis of iSNVs to identify and characterize the functional properties of non-synonymous mutations found in ORF-1 a/b, S, and N genes. Lastly, we detected a minority variant in non-vaccinated patients in Kenya, with an immune escape mutation S255F of the spike gene, and showed differential recombinant RNA species. Overall, this work identified unique in vivo mutations and intrahost recombination patterns in SARS-CoV-2, which could have significant implications for virus evolution, virulence, and immune escape.
format Journal Article
id CGSpace174472
institution CGIAR Consortium
language Inglés
publishDate 2025
publishDateRange 2025
publishDateSort 2025
publisher American Society for Microbiology
publisherStr American Society for Microbiology
record_format dspace
spelling CGSpace1744722025-12-08T09:54:28Z Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population Lugano, Doreen Mwangi, Kennedy Mware, Bernard Kibet, Gilbert Osiany, Shebbar Kiritu, Edward Dobi, Paul Muli, Collins Njeru, Regina Oliveira, T. de Njenga, M.K. Routh, A. Oyola, Samuel O. Schultz-Cherry, Stacey covid-19 health Vaccination is a key control measure of coronavirus disease 2019 by preventing severe effects of disease outcomes, reducing hospitalization rates and death, and increasing immunity. However, vaccination can affect the evolution and adaptation of SARS-CoV-2 largely through vaccine-induced immune pressure. Here, we investigated intrahost recombination and single nucleotide variations (iSNVs) on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome in non-vaccinated and vaccinated sequences from the Kenyan population to profile intrahost viral genetic evolution and adaptations driven by vaccine-induced immune pressure. We identified recombination hotspots in the S, N, and ORF1a/b genes and showed the genetic evolution landscape of SARS-CoV-2 by comparing within- and inter-wave recombination events from the beginning of the pandemic (June 2020 to December 2022) in Kenya. We further reveal differential expression of recombinant RNA species between vaccinated and non-vaccinated individuals and perform an in-depth analysis of iSNVs to identify and characterize the functional properties of non-synonymous mutations found in ORF-1 a/b, S, and N genes. Lastly, we detected a minority variant in non-vaccinated patients in Kenya, with an immune escape mutation S255F of the spike gene, and showed differential recombinant RNA species. Overall, this work identified unique in vivo mutations and intrahost recombination patterns in SARS-CoV-2, which could have significant implications for virus evolution, virulence, and immune escape. 2025-06-17 2025-05-08T06:31:11Z 2025-05-08T06:31:11Z Journal Article https://hdl.handle.net/10568/174472 en Open Access American Society for Microbiology Lugano, D., Mwangi, K., Mware, B., Kibet, G., Osiany, S., Kiritu, E., Dobi, P., Muli, C., Njeru, R., Oliveira T. de, Njenga, M.K., Routh, A. and Oyola, S.O. 2025. Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population. Journal of Virology 99(6): e00482-25.
spellingShingle covid-19
health
Lugano, Doreen
Mwangi, Kennedy
Mware, Bernard
Kibet, Gilbert
Osiany, Shebbar
Kiritu, Edward
Dobi, Paul
Muli, Collins
Njeru, Regina
Oliveira, T. de
Njenga, M.K.
Routh, A.
Oyola, Samuel O.
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population
title Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population
title_full Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population
title_fullStr Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population
title_full_unstemmed Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population
title_short Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population
title_sort characterization of sars cov 2 intrahost genetic evolution in vaccinated and non vaccinated patients from the kenyan population
topic covid-19
health
url https://hdl.handle.net/10568/174472
work_keys_str_mv AT luganodoreen characterizationofsarscov2intrahostgeneticevolutioninvaccinatedandnonvaccinatedpatientsfromthekenyanpopulation
AT mwangikennedy characterizationofsarscov2intrahostgeneticevolutioninvaccinatedandnonvaccinatedpatientsfromthekenyanpopulation
AT mwarebernard characterizationofsarscov2intrahostgeneticevolutioninvaccinatedandnonvaccinatedpatientsfromthekenyanpopulation
AT kibetgilbert characterizationofsarscov2intrahostgeneticevolutioninvaccinatedandnonvaccinatedpatientsfromthekenyanpopulation
AT osianyshebbar characterizationofsarscov2intrahostgeneticevolutioninvaccinatedandnonvaccinatedpatientsfromthekenyanpopulation
AT kirituedward characterizationofsarscov2intrahostgeneticevolutioninvaccinatedandnonvaccinatedpatientsfromthekenyanpopulation
AT dobipaul characterizationofsarscov2intrahostgeneticevolutioninvaccinatedandnonvaccinatedpatientsfromthekenyanpopulation
AT mulicollins characterizationofsarscov2intrahostgeneticevolutioninvaccinatedandnonvaccinatedpatientsfromthekenyanpopulation
AT njeruregina characterizationofsarscov2intrahostgeneticevolutioninvaccinatedandnonvaccinatedpatientsfromthekenyanpopulation
AT oliveiratde characterizationofsarscov2intrahostgeneticevolutioninvaccinatedandnonvaccinatedpatientsfromthekenyanpopulation
AT njengamk characterizationofsarscov2intrahostgeneticevolutioninvaccinatedandnonvaccinatedpatientsfromthekenyanpopulation
AT routha characterizationofsarscov2intrahostgeneticevolutioninvaccinatedandnonvaccinatedpatientsfromthekenyanpopulation
AT oyolasamuelo characterizationofsarscov2intrahostgeneticevolutioninvaccinatedandnonvaccinatedpatientsfromthekenyanpopulation